MEDIC — Medicon Hellas SA Cashflow Statement
0.000.00%
- €12.64m
- €15.50m
- €17.95m
Annual cashflow statement for Medicon Hellas SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 4.78 | 3.66 | 1.67 | 1.55 | 2.07 |
| Depreciation | |||||
| Non-Cash Items | 0.634 | -0.545 | 0.239 | 0.146 | -0.22 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.31 | -3.49 | -2.73 | -1.45 | 1.04 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 4.79 | 1.25 | 0.878 | 2 | 4.41 |
| Capital Expenditures | -0.554 | -0.408 | -1.59 | -1.01 | -1.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.239 | 0.193 | 0.611 | 0.607 | 0.179 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.316 | -0.215 | -0.984 | -0.398 | -1.32 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.32 | -1.18 | -1.64 | -1.55 | -0.925 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.16 | -0.148 | -1.75 | 0.048 | 2.16 |